Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population

Abel Romero-Corral1, Justo Sierra-Johnson, Francisco Lopez-Jimenez

  • 1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA.

Insights

High leptin levels independently predict cardiovascular disease (CVD) risk in both men and women. While C-reactive protein (CRP) alone does not predict CVD, combined leptin and CRP levels indicate the highest risk.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Disease Research
  • Inflammation Biomarkers

Background:

  • Leptin, a key regulator of appetite and metabolism, may influence C-reactive protein (CRP) levels, a marker of systemic inflammation.
  • Both leptin and CRP are recognized predictors of cardiovascular disease (CVD).
  • The precise interplay between leptin, CRP, and their combined association with CVD risk remains incompletely understood.

Purpose of the Study:

  • To investigate the independent and combined associations of leptin and CRP levels with cardiovascular disease (CVD) in a large, multiethnic population.
  • To determine if leptin or CRP are independent predictors of CVD after adjusting for each other and other cardiovascular risk factors.

Main Methods:

  • Analysis of leptin, CRP levels, anthropometric data, and cardiovascular risk factors from 6,251 participants in the Third National Health and Nutrition Examination Survey (NHANES III).
  • Logistic regression modeling to assess the association between leptin, CRP, and CVD (defined as history of myocardial infarction or stroke).
  • Receiver operating characteristic (ROC) curve analysis to evaluate the incremental predictive value of leptin and CRP for CVD.

Main Results:

  • High leptin levels were significantly associated with increased CVD risk in both men (OR 2.47) and women (OR 3.30) after adjusting for multiple confounders, including CRP.
  • Elevated CRP levels were not significantly associated with CVD risk after adjustment for leptin.
  • A significant positive correlation was observed between leptin and CRP levels in both sexes (rho = 0.22 in men, rho = 0.32 in women, P < 0.0001).
  • The addition of both leptin and CRP together significantly improved the predictive ability for CVD compared to traditional risk factors alone.

Conclusions:

  • High leptin levels are an independent predictor of cardiovascular disease (CVD), even when C-reactive protein (CRP) levels are accounted for.
  • Elevated CRP levels do not appear to be an independent predictor of CVD when leptin levels are considered.
  • The combination of elevated leptin and CRP concentrations confers the highest risk for developing cardiovascular disease.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...